• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Exopharm

Exopharm

  • Home
  • Products
  • Partnering
  • Science
  • Resources
    • ASX Announcements
    • News & Articles
  • About Us
    • Our Values
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Contact

Partnering

Technology Platform and Partnering Strategy

Exopharm is investing in two interrelated technologies to support partnering transactions with exosomes:

1. Exosome Technologies

Leveraging our LEAP technology, Exoria and other intellectual property.

Licensing the LEAP technology and Exoria exosome labelling technology, alongside Exopharm’s expert bioprocessing know-how to:

  • Empower contract manufacturing organisations to serve exosome companies.
  • Integrate LEAP into the GMP processes of biotechnology companies, including blood plasma fractionators, blood services, and emerging exosome companies.
2. Exosome Medicines

Leveraging our LOAD and EVPS technologies.

Using exosomes to deliver transformative medicines

  • Enabling Biopharma companies to deliver new and existing drug candidates in novel ways.
  • Designing and evaluating entirely new exosome medicines.

Our manufacturing expertise and intellectual property solve key EV manufacturing problems and demonstrate our leadership in this burgeoning space.

 

Exopharm is rapidly expanding its exosome portfolio, from engineering exosomes to isolation, characterisation and functional research. If you are conducting research into exosomes, it is likely that Exopharm’s platform of technology could accelerate your work. If you have unique IP in the field, it may have value for Exopharm. Contact us to initiate in-licensing or collaborative research discussions: partnering@exopharm.com

Partnering with Exopharm

Exopharm is actively seeking partnerships with biopharmaceutical companies with interest in bringing exosome-based medicines to their therapeutic areas.

What Exopharm brings to partnerships:

Clinical-scale manufacturing

LEAP Technology enables:
-Fast and cost-effective exosome isolation from biofluids or culture media including platelets, mesenchymal stem cells, iPSCs, other cells (e.g. CAR-T cells)
-Maximum yield from micro-liter bench-scale to multi-liter bioreactor scale volumes with full preservation of exosome integrity
-GMP purification of exosomes for clinical applications

LOADing specialised cargo

Exopharm’s loading technology enables the insertion of specially-designed nucleic acids to the payloads of exosomes. Nucleic acids including mRNA, RNAi and siRNA can modify how cells operate.

Targeted delivery

Exopharm’s proprietary technology enables the attachment of custom proteins to the surface of exosomes. This allows targeting of exosomes to selected cell types.

Analytics & characterization

Exopharm holds a comprehensive suite of EV characterization and analysis technologies along with deep experience in EV medicine formulation, assays and release.

Dedicated BD Scientists

Exopharm is so committed to making partnerships successful that we have senior researchers directly integrated into our partnership team. Partnering with Exopharm means fast and meaningful results that will de-risk and size opportunities quickly.

A partnership with Exopharm can:

  • Translate exosome potential in your target therapeutic area (such as neurology, cancer, or autosomal diseases) into legitimate development plans
  • Quickly de-risk exosome investments
  • Accelerate product-to-market timelines
  • Solve manufacturing challenges early to kick-start non-clinical and clinical trials
  • Provide a layer of patent protection to future offerings, either through new composition of matter IP using EVs (extend patent life of APIs) or by adding proprietary processes early in product development

Partner with Exopharm to jointly push the boundaries in transformative medicine and to expedite the development of exosome-based therapies for patients.

Contact us to initiate partnering discussions: partnering@exopharm.com

Footer

Resources

  • ASX Announcements
  • Board of Directors
  • News & Articles

Information

  • Contact
  • Partnering
  • Join Our Mailing List
  • Privacy, Terms and Conditions
  • Facebook
  • LinkedIn
  • Twitter
  • Vimeo
Copyright © 2023 · Exopharm · ACN 163 765 991 · info@exopharm.com
Level 17/31 Queen St, Melbourne VIC Australia 3000 · P: +61 (0)3 9111 0026 ·

Web Design by Mallee Blue Media
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT